Trial ID : SE-0004

Trial title

A Phase I-IIa Study of Dose-escalating Intravesical AdCD40L instillation in Urinary Bladder Carcinoma

Trial country

Sweden

Category

Cancer diseases

Indication

Bladder carcinoma

Phase

Phase I/II

Date approved/initiated

2006-03-24

Status

Closed

Date closed

2009-10

Gene(s)

CD154 (CD40-ligand)

Gene type(s)

Antigen

Vector

Adenovirus

Cell source

Target cells

Gene delivery

Administration route

Principal investigator

Uppsala University, Division of Clinical Immunolog
Uppsala
Sweden

Results reference

Clin Cancer Res. 2010 Jun 15;16(12):3279-87. Epub 2010 May 4.